A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy

Nuclear Medicine Communications

Volumn 33, Issue 1, 2012, Pages 51-59

  Petri, Sipola ^a   Esko, Vanninen ^b   Esa, Jantunen ^a   Tapio, Nousiainen ^a   Mikko, Kiviniemi ^a   Juha, Hartikainen ^a   Taru, Kuittinen ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Department of Clinical Physiology and Nuclear Medicine ^*  (Finland)

Author keywords

anthracycline chemotherapy; cardiac magnetic resonance imaging; cardiotoxicity; left ventricular ejection fraction; non Hodgkin lymphoma; radionuclide ventriculography

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ERYTHROCYTE TC 99M; FOLIC ACID; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; CANCER CHEMOTHERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MEGADOSE; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PATIENT MONITORING; RADIOISOTOPE VENTRICULOGRAPHY; REPRODUCIBILITY; REVIEW;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIONUCLIDE VENTRICULOGRAPHY; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 82555176568     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834bfec4     Document Type: Review

References (43)

1. Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, et al. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med 1979; 6:278-283. (Pubitemid 9115687)
2. Schwartz RG, McKenzie WB, Alexander J, Sager P, D'Souza A, Manatunga A, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med 1987; 6:1109-1118.
3. Jurcut R,Wildiers H, Ganame J, D'Hooge J, Paridaens R, Voigt JU. Detection and monitoring of cardiotoxicity -what does modern cardiology offer? Support Care Cancer 2008; 5:437-445.
4. Haq MM, Legha SS, Choksi J, Sager P, D'Souza A, Manatunga A, et al. Doxorubicin-induced congestive heart failure in adults. Cancer 1985; 6:1361-1365. (Pubitemid 15230583)
5. Von Hoff DD, Layard MW, Basa P, Davis HL Jr., Von Hoff AL, Rozencweig M, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 5:710-717. (Pubitemid 10218041)
6. Lahtinen R, Kuikka J, Nousiainen T, Uusitupa M, Länsimies E. Cardiotoxicity of epirubicin and doxorubicin: A double-blind randomized study. Eur J Haematol 1991; 5:301-305.
7. Nousiainen T, Jantunen E, Vanninen E, Hartikainen J. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients. Br J Cancer 2002; 11:1697-1700. (Pubitemid 34712910)
8. GanzWI, Sridhar KS, Ganz SS, Gonzalez R, Chakko S, Serafini A. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncol 1996; 6:461-470. (Pubitemid 26388387)
9. Steinherz LJ, Graham T, Hurwitz R, Sondheimer HM, Schwartz RG, Shaffer EM, et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 1992; 5 (Pt 1):942-949.
10. Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, et al. Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy. J Intern Med 2001; 4:297-303. (Pubitemid 34293776)
11. Oberholzer K, Kunz RP, Dittrich M, Thelen M. Anthracycline-induced cardiotoxicity: Cardiac MRI after treatment for childhood cancer. Rofo 2004; 9:1245-1250. (Pubitemid 39237183)
12. Wassmuth R, Lentzsch S, Erdbruegger U, Schulz-Menger J, Doerken B, Dietz R, et al. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. Am Heart J 2001; 6: 1007-1013. (Pubitemid 32477014)
13. Hendel RC, Patel MR, Kramer CM, Poon M, Hendel RC, Carr JC, et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: A report of the American College of Cardiology foundation quality strategic directions committee appropriateness criteria working group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006; 48:1475-1497.
14. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 5:1361-1392. (Pubitemid 24273002)
15. Sipola P, Lauerma K, Jääskelänen P, Laakso M, Peuhkurinen K, Manninen H, et al. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene. Radiology 2005; 3:815-824. (Pubitemid 41170842)
16. Dulce MC, Mostbeck GH, Friese KK, Caputo GR, Higgins CB. Quantification of the left ventricular volumes and function with cine MR imaging: Comparison of geometric models with three-dimensional data. Radiology 1993; 2:371-376. (Pubitemid 23216254)
17. Cohen J. Statistical power analysis for the behavioral sciences. New Jersey: Lawrence Erlbaum Associates; 1988.
18. Chen B, Peng X, Pentassuglia L, Lim CC, Sawyer DB. Molecular and cellular mechanisms of anthracycline cardiotoxicity. Cardiovasc Toxicol 2007; 2:1530-7905.
19. Thorburn A, Frankel AE. Apoptosis and anthracycline cardiotoxicity. Molecular Cancer Therapeutics 2006; 2:197-199.
20. Vergely C, Delemasure S, Cottin Y, Rochette L. Preventing the cardiotoxic effects of anthracyclines; from basic concepts to clinical data. Heart Metab 2007; 35:1-7.
21. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 12:808-815.
22. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJS, Cleland JGF, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J 2000; 16:1387-1396. (Pubitemid 30599134)
23. Jensen FT, Lund O, Erlandsen M. Reliability of three computer methods in the analysis of ECG-gated radionuclide left ventriculography: Interrecording, interobserver and intraobserver variability. Angiology 1991; 11:866-877.
24. Pfisterer ME, Battler A, Swanson SM, Slutsky R, Froelicher V, Ashburn WL. Reproducibility of ejection-fraction determinations by equilibrium radionuclide angiography in response to supine bicycle exercise: Concise communication. J Nucl Med 1979; 6:491-495. (Pubitemid 9182851)
25. Reiber JH, Lie SP, Simoons ML, Hoek C, Gerbrands JJ, Wijns W, et al. Clinical validation of fully automated computation of ejection fraction from gated equilibrium blood-pool scintigrams. J Nucl Med 1983; 12: 1099-1107. (Pubitemid 14218701)
26. Slutsky R, Karliner J, Battler A, Pfisterer M, Swanson S, Ashburn W. Reproducibility of ejection fraction and ventricular volume by gated radionuclide angiography after myocardial infarction. Radiology 1979; 1: 155-159. (Pubitemid 9191839)
27. Wackers FJ, Berger HJ, Johnstone DE, Goldman L, Reduto LA, Langou RA, et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: Validation of the technique and assessment of variability. Am J Cardiol 1979; 6:1159-1166. (Pubitemid 9190999)
28. Ewer MS, Lenihan DJ. Left ventricular ejection fraction and cardiotoxicity: Is our ear really to the ground? J Clin Oncol 2008; 8:1201-1203.
29. Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 1:29-34. (Pubitemid 34671198)
30. Pattynama PM, Lamb HJ, van der Velde EA, van derWall EE, de Roos A. Left ventricular measurements with cine and spin-echo MR imaging: A study of reproducibility with variance component analysis. Radiol 1993; 1:261-268. (Pubitemid 23097896)
31. Semelka RC, Tomei E, Wagner S, Mayo J, Caputo G, O'Sullivan M, et al. Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 1990; 6:1367-1373. (Pubitemid 20215623)
32. Gaudio C, Tanzilli G, Mazzarotto P, Motolese M, Romeo F, Marino B, et al. Comparison of left ventricular ejection fraction by magnetic resonance imaging and radionuclide ventriculography in idiopathic dilated cardiomyopathy. Am J Cardiol 1991; 5:411-415.
33. Bellenger NG, Marcus NJ, Rajappan K, Yacoub M, Banner NR, Pennell DJ. Comparison of techniques for the measurement of left ventricular function following cardiac transplantation. J Cardiovasc Magn Reson 2002; 2: 255-263. (Pubitemid 34596286)
34. Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, et al. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. J Intern Med 2002; 3:228-234. (Pubitemid 34227187)
35. Seals AA, Verani MS, Tadros S, Mahmarian JJ, Roberts R. Comparison of left ventricular diastolic function as determined by nuclear cardiac probe, radionuclide angiography, and contrast cineangiography. J Nucl Med 1986; 12:1908-1915. (Pubitemid 17206139)
36. Patel D, Robinson VJ, Arteaga RB, Thornton JW. Diastolic filling parameters derived from myocardial perfusion imaging can predict left ventricular enddiastolic pressure at subsequent cardiac catheterization. J Nucl Med 2008; 5:746-751. (Pubitemid 351717539)
37. Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, et al. Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: A prospective radionuclide ventriculographic and echocardiographic study. Leuk Lymphoma 2002; 9:1807-1811. (Pubitemid 34874015)
38. Hoff FL, Turner DA, Wang JZ, Barron JT, Chutuape MD, Liebson PR. Semiautomatic evaluation of left ventricular diastolic function with cine magnetic resonance imaging. Acad Radiol 1994; 3:237-242.
39. Tseng WY, Liao TY,Wang JL. Normal systolic and diastolic functions of the left ventricle and left atrium by cine magnetic resonance imaging. J Cardiovasc Magn Reson 2002; 4:443-457.
40. Nomura Y, Inoue Y, Yokoyama I, Nakaoka T, Itoh D, Okubo T, et al. Evaluation of left ventricular function with cardiac magnetic resonance imaging using Fourier fitting. Magn Reson Imaging 2006; 10:1333-1339. (Pubitemid 44827588)
41. Bacharach SL, Green MV, Borer JS, Hyde JE, Farkas SP, Johnston GS. Leftventricular peak ejection rate, filling rate, and ejection fraction -frame rate requirements at rest and exercise. Concise communication. J Nucl Med 1979; 3:189-193.
42. Gunnes S, Storaa C, Lind B, Nowak J, Brodin LA. Analysis of the effect of temporal filtering in myocardial tissue velocity imaging. J Am Soc Echocardiogr 2004; 11:1138-1145. (Pubitemid 39402972)
43. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF. MR evaluation of ventricular function: True fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: Feasibility study. Radiology 2001; 1:264-269. (Pubitemid 32234085)